Back to BlackRock, Inc. BlackRock, Inc.

NAMSNAMS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in NEWAMSTERDAM PHARMA COMPANY

BlackRock, Inc. holds 1.1M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $36.1M as of 2026-Q2. The position was increased (+20.0% shares). NAMS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$36.1M

Current Shares

1.1M

Total Value Change

+$24.7M

Total Shares Change

+622,232

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+20.0%
$36.1M0.0%$33.89
34
2026-Q1
Increased
886,616
+4.3%
$28.4M0.0%$30.41
30
2025-Q4
Increased
849,779
+36.5%
$29.8M0.0%$34.74
38
2025-Q3
Increased
622,515
+8.9%
$17.7M0.0%$27.52
31
2025-Q2
Increased
571,673
+14.8%
$10.4M0.0%$18.57
32
2025-Q1
Increased
497,981
+12.8%
$10.2M0.0%$21.76
31
2024-Q4
New
441,518
-
$11.3M0.0%$25.60
39

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used